Venus Remedies Limited has scheduled a meeting of its Board of Directors for July 20, 2026. The primary agenda for this meeting includes:

  • Consideration and approval of Unaudited Standalone Financial Results for the period ended June 30, 2026
  • Consideration and approval of Unaudited Consolidated Financial Results for the period ended June 30, 2026
  • Any other business with the permission of the Chair

Trading Window Closure

Pursuant to SEBI Prevention of Insider Trading regulations, the company has closed the trading window for designated persons from July 1, 2026. The trading restriction will remain in effect until 48 hours after the declaration of the financial results.